Last reviewed · How we verify

Bone regeneration

São Paulo State University · FDA-approved active Biologic

Bone regeneration therapy stimulates osteogenic differentiation and new bone formation through biological or biomaterial-based approaches.

Bone regeneration therapy stimulates osteogenic differentiation and new bone formation through biological or biomaterial-based approaches. Used for Bone defects and fractures requiring regeneration.

At a glance

Generic nameBone regeneration
Also known asBio-Oss Collagen®, Bio-Gide®
SponsorSão Paulo State University
ModalityBiologic
Therapeutic areaOrthopedics / Regenerative Medicine
PhaseFDA-approved

Mechanism of action

This marketed product from São Paulo State University facilitates bone regeneration, likely through scaffolding materials, growth factor delivery, or stem cell-based strategies that promote osteoblast activity and mineralized matrix deposition. The exact mechanism depends on the specific formulation, which may involve biocompatible polymers, hydroxyapatite, or cellular components that create an environment conducive to bone healing and remodeling.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: